The present invention relates to a method of reducing body weight orhyperphagia inPrader-Willi patients comprising administering the active compound Tesofensineor apharmaceutically acceptable salt thereof, preferably by the administration ofacontrolled release formulation comprising the active compounds tesofensine anda betablocker.